Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma

OBJECTIVE: Treatment of differentiated thyroid carcinoma (DTC) includes suppression of TSH with levothyroxine therapy, which may negatively influence bone mineral density (BMD), but the effects are controversial. We aimed to evaluate the relationship between TSH-suppressive therapy and BMD in postme...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Thyroid Res
Главные авторы: de Melo, Thaís Gomes, da Assumpção, Lígia Vera Montalli, Santos, Allan de Oliveira, Zantut-Wittmann, Denise Engelbrecht
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474343/
https://ncbi.nlm.nih.gov/pubmed/26097507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13044-015-0019-1
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы